Skip to main content
OpenTrials
Completed

NCT Number: NCT02595411

Reliability of the Melbourne Assessment

The aim of the study is to investigate the reliability of the Melbourne Assessment.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Children with central motor disorders will be tested twice within one week with the Melbourne Assessment. The assessments will be video scored. At a later time point, different raters will rate the same video for inter-rater reliability, the same rater will score the same video for intra-rater reliability, and the same rater will score the repeated assessment videos for test-retest reliability.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • central motor disorders
  • ambulant or stationary patients of the Rehabilitation Center Affoltern am Albis
  • ability to understand test instructions
  • ability to sit upright for 25 minutes
  • minimal activity in the assessed upper limb

Exclusion criteria

  • severe visual and/or auditory problems
  • acute lesion in the to assessed upper limb
  • lack of compliance

Treatment and study plan

Primary outcomes

  1. Melbourne Assessment 2

    Time frame: 2 assessments within 1 week

    Assessment to measure unilateral upper limb function

Sponsors and collaborators

Lead sponsor

University Children's Hospital, Zurich

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Nov 3, 2015
Registry last updated
Feb 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.